Low-dose tamoxifen for combination hormone replacement therapy users

被引:3
作者
Fabian, Carol J. [1 ]
机构
[1] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA
关键词
ITALIAN RANDOMIZED-TRIAL; ESTROGEN-PLUS-PROGESTIN; BREAST-CANCER; POSTMENOPAUSAL WOMEN; DENSITY; RISK; HYSTERECTOMY; PREVENTION;
D O I
10.1200/JCO.2007.11.9743
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:4162 / 4164
页数:3
相关论文
共 23 条
[1]   Effects of conjugated, equine estrogen in postmenopausal women with hysterectomy - The women's health initiative randomized controlled trial [J].
Anderson, GL ;
Limacher, M ;
Assaf, AR ;
Bassford, T ;
Beresford, SAA ;
Black, H ;
Bonds, D ;
Brunner, R ;
Brzyski, R ;
Caan, B ;
Chlebowski, R ;
Curb, D ;
Gass, M ;
Hays, J ;
Heiss, G ;
Hendrix, S ;
Howard, BV ;
Hsia, J ;
Hubbell, A ;
Jackson, R ;
Johnson, KC ;
Judd, H ;
Kotchen, JM ;
Kuller, L ;
LaCroix, AZ ;
Lane, D ;
Langer, RD ;
Lasser, N ;
Lewis, CE ;
Manson, J ;
Margolis, K ;
Ockene, J ;
O'Sullivan, MJ ;
Phillips, L ;
Prentice, RL ;
Ritenbaugh, C ;
Robbins, J ;
Rossouw, JE ;
Sarto, G ;
Stefanick, ML ;
Van Horn, L ;
Wactawski-Wende, J ;
Wallace, R ;
Wassertheil-Smoller, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (14) :1701-1712
[2]  
Beral Valerie, 2003, Lancet, V362, P419
[3]   RELATIONSHIP BETWEEN MAMMOGRAPHIC AND HISTOLOGICAL RISK-FACTORS FOR BREAST-CANCER [J].
BOYD, NF ;
JENSEN, HM ;
COOKE, G ;
HAN, HL .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (15) :1170-1179
[4]   Hormone therapy prescribing patterns in the United States [J].
Buist, DSM ;
Newton, KM ;
Miglioretti, DL ;
Beverly, K ;
Connelly, MT ;
Andrade, S ;
Hartsfield, CL ;
Wei, FF ;
Chan, KA ;
Kessler, L .
OBSTETRICS AND GYNECOLOGY, 2004, 104 (05) :1042-1050
[5]   Tamoxifen and breast density in women at increased risk of breast cancer [J].
Cuzick, J ;
Warwick, J ;
Pinney, E ;
Warren, RML ;
Duffy, SW .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (08) :621-628
[6]  
Decensi A, 2003, RECENT RESULTS CANC, V163, P104
[7]   A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers [J].
Decensi, A ;
Robertson, C ;
Viale, G ;
Pigatto, F ;
Johansson, H ;
Kisanga, ER ;
Veronesi, P ;
Torrisi, R ;
Cazzaniga, M ;
Mora, S ;
Sandri, MT ;
Pelosi, G ;
Luini, A ;
Goldhirsch, A ;
Lien, EA ;
Veronesi, U .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (11) :779-790
[8]   Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy users [J].
Decensi, Andrea ;
Gandini, Sara ;
Serrano, Davide ;
Cazzaniga, Massimiliano ;
Pizzamiglio, Maria ;
Maffini, Fausto ;
Pelosi, Giuseppe ;
Daldoss, Cristina ;
Omodei, Umberto ;
Johansson, Harriet ;
Macis, Debora ;
Lazzeroni, Matteo ;
Penotti, Mauro ;
Sironi, Laura ;
Moroni, Simona ;
Bianco, Vanda ;
Rondanina, Gabriella ;
Gjerde, Jennifer ;
Guerrieri-Gonzaga, Aliana ;
Bonanni, Bernardo .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (27) :4201-4209
[9]   Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study [J].
Fisher, B ;
Costantino, JP ;
Wickerham, DL ;
Redmond, CK ;
Kavanah, M ;
Cronin, WM ;
Vogel, V ;
Robidoux, A ;
Dimitrov, N ;
Atkins, J ;
Daly, M ;
Wieand, S ;
Tan-Chiu, E ;
Ford, L ;
Wolmark, N .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (18) :1371-1388
[10]   Endometrial protection from tamoxifen-stimulated changes by a levonorgestrel-releasing intrauterine system: a randomised controlled trial [J].
Gardner, FJE ;
Konje, JC ;
Abrams, KR ;
Brown, LJR ;
Khanna, S ;
Al-Azzawi, F ;
Bell, SC ;
Taylor, DJ .
LANCET, 2000, 356 (9243) :1711-1717